SLNCF
SLNCF
GB00B9GTXM62
Silence Therapeutics, Plc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
717.88M EUR
311.83M EUR
283.41M EUR
283.4M EUR
Enterprise Value
495.02M EUR
239.88M EUR
277.89M EUR
272.29M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-10.12x
--
--
--
Price to Sales
1,167.28x
507.03x
337.79x
679.63x
Price to Book
14.19x
8.11x
5.74x
4.55x
EV/Revenue
804.91x
390.06x
331.21x
652.97x
EV/EBITDA
-7.74x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.28%
-13.55%
-23.15%
-17.65%
ende